3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Waldenstrom Macroglobulinemia
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large-Cell, Anaplastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Prolymphocytic
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Hairy Cell
3
Leukemia, Biphenotypic, Acute
3
Immunoblastic Lymphadenopathy
3
Hodgkin Disease
3
Burkitt Lymphoma
3
Sezary Syndrome
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Extranodal NK-T-Cell
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Interventions
AP 1903 reagent
3
ON 01910
2
Biopsy
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
angiotensin I (1-7)
1
Vitamin B 12
1
Therapeutics
1
Specimen Handling
1
Sertraline
1
Pluvicto
1
Peripheral Blood Stem Cell Transplantation
1
Metformin
1
Interleukin-8
1
Immunotherapy, Adoptive
1
IDO-1 inhibitor LY3381916
1
HuMax-IL8
1
Granulocyte Colony-Stimulating Factor
1
Genetic Counseling
1
Folic Acid
1
Filgrastim
1
Exercise
1
Emapalumab
1
Decitabine
1
DNA
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytopenia
×
Therapeutics
×
Classical hematology
×
Clear all
NCT02775383
2026-02-03
MDS
National Heart, Lung, and Blood Institute (NHLBI)
Completed
2,115 enrolled